Literature DB >> 2575665

A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.

J Molgó1, L S Siegel, N Tabti, S Thesleff.   

Abstract

1. The effects of botulinum toxin (BoTx) types A and D on spontaneous and evoked phasic transmitter release were studied in the isolated extensor digitorum longus muscle of the rat or the levator auris longus muscle of mice. 2. The toxins were injected subcutaneously into the hindleg of adult rats or the dorsal aspect of the neck of mice. At various times after the injection the muscles were removed from the anaesthetized animal and neuromuscular transmission examined in vitro by conventional intracellular techniques. 3. Both toxins reduced spontaneous transmitter release recorded as the frequency of miniature end-plate potentials but BoTx type D was less effective in that respect than the type A toxin. 4. With both toxins the block of evoked phasic transmitter release, recorded as end-plate potentials, was almost complete. As previously reviewed by Simpson (1986) the block produced by BoTx type A was partially reversed by procedures which elevate the intraterminal level of calcium ions. However, in BoTx type D-paralysed muscles such procedures failed to restore phasic transmitter release but caused a period of high-frequency asynchronous transmitter release following each nerve impulse. 5. To investigate if the lack of synchronization of evoked transmitter release observed in BoTx type D-paralysed muscles was due to alterations in presynaptic currents we examined, by perineural recordings, the Na+, fast K+, slow K+, K+-Ca2+-dependent and the Ca2+ currents in BoTx type D-paralysed muscles. These presynaptic currents were not altered as compared to unpoisoned controls. 6. We suggest that there exists a presynaptic process, which in addition to Ca2+ influx participates in transmitter synchronization and which is a main target for BoTx type D action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575665      PMCID: PMC1190519          DOI: 10.1113/jphysiol.1989.sp017568

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  22 in total

1.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Electric current flow inside perineurial sheaths of mouse motor nerves.

Authors:  A Mallart
Journal:  J Physiol       Date:  1985-11       Impact factor: 5.182

3.  The actions of presynaptic snake toxins on membrane currents of mouse motor nerve terminals.

Authors:  F Dreyer; R Penner
Journal:  J Physiol       Date:  1987-05       Impact factor: 5.182

4.  The levator auris longus muscle of the mouse: a convenient preparation for studies of short- and long-term presynaptic effects of drugs or toxins.

Authors:  D Angaut-Petit; J Molgo; A L Connold; L Faille
Journal:  Neurosci Lett       Date:  1987-11-10       Impact factor: 3.046

5.  The antagonism between botulinum toxin and calcium in motor nerve terminals.

Authors:  C B Gundersen; B Katz; R Miledi
Journal:  Proc R Soc Lond B Biol Sci       Date:  1982-10-22

6.  3,4-diaminopyridine. A potent new potassium channel blocker.

Authors:  G E Kirsch; T Narahashi
Journal:  Biophys J       Date:  1978-06       Impact factor: 4.033

7.  Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction.

Authors:  J A Kauffman; J F Way; L S Siegel; L C Sellin
Journal:  Toxicol Appl Pharmacol       Date:  1985-06-30       Impact factor: 4.219

8.  Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature.

Authors:  F Dreyer; A Schmitt
Journal:  Pflugers Arch       Date:  1983-11       Impact factor: 3.657

9.  Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.

Authors:  L C Sellin; S Thesleff; B R Dasgupta
Journal:  Acta Physiol Scand       Date:  1983

10.  Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction.

Authors:  L C Sellin; S Thesleff
Journal:  J Physiol       Date:  1981-08       Impact factor: 5.182

View more
  11 in total

Review 1.  The kinetics of nerve-evoked quantal secretion.

Authors:  R Fesce
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

2.  SNARE proteins contribute to calcium cooperativity of synaptic transmission.

Authors:  B A Stewart; M Mohtashami; W S Trimble; G L Boulianne
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Synchronization of evoked secretion of quanta of mediator as a mechanism facilitating the action of sympathomimetics.

Authors:  E A Bukharaeva; K K Kim; E E Nikol'skii; F Vyskochil
Journal:  Neurosci Behav Physiol       Date:  2000 Mar-Apr

4.  Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions.

Authors:  E A Bukcharaeva; K C Kim; J Moravec; E E Nikolsky; F Vyskocil
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

5.  Modulation of calcium currents is eliminated after cleavage of a strategic component of the mammalian secretory apparatus.

Authors:  Eugene M Silinsky
Journal:  J Physiol       Date:  2005-06-16       Impact factor: 5.182

6.  Selective disruption of the mammalian secretory apparatus enhances or eliminates calcium current modulation in nerve endings.

Authors:  Eugene M Silinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-17       Impact factor: 11.205

7.  Modulation of an early step in the secretory machinery in hippocampal nerve terminals.

Authors:  L E Trudeau; Y Fang; P G Haydon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  The Relevance of AgRP Neuron-Derived GABA Inputs to POMC Neurons Differs for Spontaneous and Evoked Release.

Authors:  Andrew R Rau; Shane T Hentges
Journal:  J Neurosci       Date:  2017-06-30       Impact factor: 6.167

9.  Prevention of diisopropylphosphorofluoridate-induced myopathy by botulinum toxin type A blockage of quantal release of acetylcholine.

Authors:  D Sket; W D Dettbarn; M E Clinton; K E Misulis; J Sketelj; D Cucek; M Brzin
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 10.  Botulinum Toxin Type A-A Modulator of Spinal Neuron-Glia Interactions under Neuropathic Pain Conditions.

Authors:  Ewelina Rojewska; Anna Piotrowska; Katarzyna Popiolek-Barczyk; Joanna Mika
Journal:  Toxins (Basel)       Date:  2018-04-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.